Enrique Samper Rodriguez

Director Ejecutivo en NIMGenetics Genómica y Medicina SL .

Health Technology

Commercial Services

Perfil

Enrique Samper Rodriguez is the founder and current Director of Gene Predictis SA. He founded NIMGenetics Genómica y Medicina SL in 2008 and serves as its Chief Executive Officer.

Cargos activos de Enrique Samper Rodriguez

Empresas	Cargo	Inicio
NIMGenetics Genómica y Medicina SL NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain.	Director Ejecutivo	01/01/2008
GENE PREDICTIS SA GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023.	Director/Miembro de la Junta	-

Todos los cargos activos de Enrique Samper Rodriguez

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Enrique Samper Rodriguez.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
NIMGenetics Genómica y Medicina SL NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain.	Health Technology
GENE PREDICTIS SA GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023.	Commercial Services